IE
YTEN

Israel Englander’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

Israel Englander’s Portfolio YTEN Stock Details YTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,364
Closed -$7.86K – 6785
2023
Q4 		$7.86K Sell
1,364
-939
-41% -$6.24K ﹤0.01% 5770
2023
Q3 		$18.1K Buy
+2,303
New +$57.9K ﹤0.01% 5674
2023
Q1 		– Sell
-498
Closed -$20K – 7062
2022
Q4 		$20K Sell
498
-730
-59% -$43.5K ﹤0.01% 6052
2022
Q3 		$88K Sell
1,228
-1,221
-50% -$82.4K ﹤0.01% 6010
2022
Q2 		$132K Buy
+2,449
New +$173K ﹤0.01% 5825
2022
Q1 		– Sell
-2,112
Closed -$249K – 7705
2021
Q4 		$249K Sell
2,112
-224
-10% -$29.5K ﹤0.01% 5721
2021
Q3 		$340K Sell
2,336
-77
-3% -$12.9K ﹤0.01% 5726
2021
Q2 		$494K Sell
2,413
-440
-15% -$97.9K ﹤0.01% 5322
2021
Q1 		$859K Buy
+2,853
New +$965K ﹤0.01% 4359

Other funds holding YTEN

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
CS
Cannell & Spears New York $5.62B AUM 41.25% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
CCB
Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GWM
Grand Wealth Management Grand Rapids, Michigan $240M AUM 21.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Israel Englander's YTEN Position: Q1 2024 in Review

Israel Englander sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q1 2024, closing a stake of 1,364 shares — an estimated $7.86K sold.

Israel Englander first reported a position in YTEN in Q1 2021 and held it in 9 quarters. The position peaked at $859K in Q1 2021. 19 funds tracked by Wall St. Rank hold YTEN as of Q1 2024.

  • Israel Englander reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Israel Englander sold 1,364 Yield10 Bioscience, Inc. Common Stock shares in Q1 2024, an estimated $7.86K.
  • Israel Englander first reported a position in Yield10 Bioscience, Inc. Common Stock in Q1 2021 and held it in 9 quarters.
  • Israel Englander's Yield10 Bioscience, Inc. Common Stock position peaked at $859K in Q1 2021.
  • 19 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q1 2024.

Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.